Target
EEF1AKMT4-ECE2 readthrough transcript protein
Ligand
BDBM21642
Substrate
n/a
Meas. Tech.
Enzymatic Assay
Ki
>100000±0 nM
IC50
>100000±0 nM
Citation
 Ouimet, TOrng, SVPoras, HGagnidze, KDevi, LAFournié-Zaluski, MCRoques, BP Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay. J Biol Chem 285:34390-400 (2010) [PubMed]  Article 
Target
Name:
EEF1AKMT4-ECE2 readthrough transcript protein
Synonyms:
EEF1AKMT4-ECE2 | EFCE2_HUMAN | Endothelin-converting enzyme 2 | Endothelin-converting enzyme 2 (ECE-2) | Endothelin-converting enzyme 2 (ECE2) | Endothelin-converting enzyme 2 region
Type:
Enzyme
Mol. Mass.:
99745.05
Organism:
Homo sapiens (Human)
Description:
P0DPD8
Residue:
883
Sequence:
MASPGAGRAPPELPERNCGYREVEYWDQRYQGAADSAPYDWFGDFSSFRALLEPELRPEDRILVLGCGNSALSYELFLGGFPNVTSVDYSSVVVAAMQARHAHVPQLRWETMDVRKLDFPSASFDVVLEKGTLDALLAGERDPWTVSSEGVHTVDQVLSEVGFQKGTRQLLGSRTQLELVLAGASLLLAALLLGCLVALGVQYHRDPSHSTCLTEACIRVAGKILESLDRGVSPCEDFYQFSCGGWIRRNPLPDGRSRWNTFNSLWDQNQAILKHLLENTTFNSSSEAEQKTQRFYLSCLQVERIEELGAQPLRDLIEKIGGWNITGPWDQDNFMEVLKAVAGTYRATPFFTVYISADSKSSNSNVIQVDQSGLFLPSRDYYLNRTANEKVLTAYLDYMEELGMLLGGRPTSTREQMQQVLELEIQLANITVPQDQRRDEEKIYHKMSISELQALAPSMDWLEFLSFLLSPLELSDSEPVVVYGMDYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDRRFESAQEKLLETLYGTKKSCVPRWQTCISNTDDALGFALGSLFVKATFDRQSKEIAEGMISEIRTAFEEALGQLVWMDEKTRQAAKEKADAIYDMIGFPDFILEPKELDDVYDGYEISEDSFFQNMLNLYNFSAKVMADQLRKPPSRDQWSMTPQTVNAYYLPTKNEIVFPAGILQAPFYARNHPKALNFGGIGVVMGHELTHAFDDQGREYDKEGNLRPWWQNESLAAFRNHTACMEEQYNQYQVNGERLNGRQTLGENIADNGGLKAAYNAYKAWLRKHGEEQQLPAVGLTNHQLFFVGFAQVWCSVRTPESSHEGLVTDPHSPARFRVLGTLSNSRDFLRHFGCPVGSPMNPGQLCEVW
  
Inhibitor
Name:
BDBM21642
Synonyms:
(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid | CHEMBL1560 | Capozide | Captopril | Lopirin | SQ 14,225 | SQ14534 | US11491146, Compound L-Captopril
Type:
Small organic molecule
Emp. Form.:
C9H15NO3S
Mol. Mass.:
217.285
SMILES:
C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
Structure:
Search PDB for entries with ligand similarity: